Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Ascending
Jan 27, 2010 roberts william Officer Automatic Sell 4,381 26.57
May 14, 2010 vagelos p roy Director Sell 20,000 26.96 - 27.19
Jun 14, 2010 ryan arthur f Director Buy 10,000 26.98
Jan 27, 2010 kolinski stuart Officer Automatic Sell 4,359 27.00
Feb 2, 2010 kolinski stuart Officer Automatic Sell 6,913 27.16
Feb 2, 2010 roberts william Officer Automatic Sell 9,671 27.16 - 27.48
Oct 4, 2010 goldstein joseph l Director Automatic Sell 6,848 27.45
Feb 4, 2010 roberts william Officer Automatic Sell 514 27.48 - 28.38
May 14, 2010 goldstein joseph l Director Disposition (Non Open Market) 4,600 27.63
Feb 3, 2010 kolinski stuart Officer Automatic Sell 5,401 27.66 - 28.08
Feb 3, 2010 roberts william Officer Automatic Sell 3,315 27.66 - 28.08
May 19, 2010 brown michael s Director Sell 524 27.73
May 27, 2010 gilman alfred g Director Disposition (Non Open Market) 4,553 27.92
Feb 2, 2010 mccorkle douglas s Officer Automatic Sell 5,875 28.00
Oct 13, 2010 sanofi Beneficial Owner (10% or more) Buy 1,017,401 28.00
Dec 16, 2011 schleifer leonard s Officer Option Execute 250,000 28.01
Aug 31, 2011 vagelos p roy Officer Option Execute 312,500 28.01
Nov 30, 2011 yancopoulos george Officer Option Execute 200,000 28.01
Feb 3, 2010 goldberg murray a Officer Automatic Sell 13,895 28.02
Oct 7, 2010 brown michael s Director Automatic Sell 1,765 28.03
Showing 381-400 of 773 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)